← brief for 2026-08-12 · Slowing decline

The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This paper combined the results of several randomized trials of RAAS inhibitors, a type of blood pressure drug, in people with IgA nephropathy. IgA nephropathy is a kidney disease where the filters get inflamed. Pooling many trials this way is the strongest kind of evidence. It measured how these drugs affected the kidneys across the trials.

Who did this work

Rastogi A · Sarkar M · Kawai K · Munoz G · Simon L · Hwang M · Khalid M · Rhee C

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 12
https://pubmed.ncbi.nlm.nih.gov/42584957/